Site for Site for CTN-0100: Optimizing Retention Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Opioid Use Disorder
  • Age: Between 18 Year(s) - 99 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    Retention Phase
    1. Participants will provide written informed consent
    2. Meet DSM-5 criteria for current opioid use disorder
    3. Seeking treatment for opioid use disorder and choosing either buprenorphine (BUP) or extended-rele

You may not be eligible for this study if the following are true:

  • Retention Phase
    1. Serious medical, psychiatric, or co-occurring substance use disorder that, in the opinion of the study medical clinician, makes the patient not appropriate for outpatient treatment with buprenorphine or XR- NTX but instead requ


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.